UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 84

Sortiert nach

Extracellular vesicles in urological malignancies: an update

Nature reviews. Urology, 2020-01, Vol.17 (1), p.11-27

2020

Link zum Volltext

Verfügbarkeit prüfen

177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)

European journal of nuclear medicine and molecular imaging, 2022-02, Vol.49 (3), p.1075-1085

2022

Link zum Volltext

Verfügbarkeit prüfen

Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model

Scientific reports, 2020-07, Vol.10 (1), p.12575-12575, Article 12575

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model

Scientific reports, 2024-04, Vol.14 (1), p.8835-8835

2024

Link zum Volltext

Verfügbarkeit prüfen

New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide

European journal of nuclear medicine and molecular imaging, 2020-03, Vol.47 (3), p.687-694

2020

Link zum Volltext

Verfügbarkeit prüfen

Structure of the mammalian oligosaccharyl-transferase complex in the native ER protein translocon

Nature communications, 2014-01, Vol.5 (1), p.3072-3072, Article 3072

2014

Link zum Volltext

Verfügbarkeit prüfen

Publisher Correction: Extracellular vesicles in urological malignancies: an update

Nature reviews. Urology, 2020-01, Vol.17 (1), p.62-62

2020

Link zum Volltext

Verfügbarkeit prüfen

Can local treatment prolong the sensitivity of metastatic prostate cancer to androgen deprivation or even prevent castration resistance?

World journal of urology, 2021-09, Vol.39 (9), p.3231-3237

2021

Link zum Volltext

Verfügbarkeit prüfen

The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors

Frontiers in physiology, 2022-10, Vol.13, p.1014271-1014271

2022

Link zum Volltext

Verfügbarkeit prüfen

Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function

Cancers, 2021-06, Vol.13 (12), p.3095

2021

Link zum Volltext

Verfügbarkeit prüfen

BiP-mediated closing of the Sec61 channel limits Ca2+ leakage from the ER

The EMBO journal, 2012-08, Vol.31 (15), p.3282-3296

2012

Link zum Volltext

Verfügbarkeit prüfen

Last Resort from Nursing Shortage? Comparative Cost Analysis of Open vs. Robot-Assisted Partial Nephrectomies with a Focus on the Costs of Nursing Care

Cancers, 2023-04, Vol.15 (8), p.2291

2023

Link zum Volltext

Verfügbarkeit prüfen

Neuron-specific enolase has potential value as a biomarker for [18F]FDG/[68Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients

EJNMMI research, 2020-05, Vol.10 (1), p.52-52, Article 52

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis

Pharmaceutics, 2021-05, Vol.13 (5), p.722

2021

Link zum Volltext

Verfügbarkeit prüfen

Primary Tumor Resection Decelerates Disease Progression in an Orthotopic Mouse Model of Metastatic Prostate Cancer

Cancers, 2022-01, Vol.14 (3), p.737

2022

Link zum Volltext

Verfügbarkeit prüfen

Histologically Confirmed Testicular Metastasis Revealed by [ 89 Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging

Diagnostics (Basel), 2023-04, Vol.13 (7), p.1352

2023

Link zum Volltext

Verfügbarkeit prüfen

Patient-derived, three-dimensional spheroid cultures provide a versatile translational model for the study of organ-confined prostate cancer

Journal of cancer research and clinical oncology, 2019-03, Vol.145 (3), p.551-559

2019

Link zum Volltext

Verfügbarkeit prüfen

Organ-Specific Uptake of Extracellular Vesicles Secreted by Urological Cancer Cells

Cancers, 2021-09, Vol.13 (19), p.4937

2021

Link zum Volltext

Verfügbarkeit prüfen

Active surveillance inclusion criteria under scrutiny in magnetic resonance imaging-guided prostate biopsy: a multicenter cohort study

Prostate cancer and prostatic diseases, 2022-03, Vol.25 (1), p.109-116

2022

Link zum Volltext

Verfügbarkeit prüfen

Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLT

Cancers, 2021-08, Vol.13 (16), p.4134

2021

Link zum Volltext

Verfügbarkeit prüfen

Addition of Standard Enzalutamide Medication Shows Synergistic Effects on Response to [ 177 Lu]Lu-PSMA-617 Radioligand Therapy in mCRPC Patients with Imminent Treatment Failure-Preliminary Evidence of Pilot Experience

Cancers, 2022-05, Vol.14 (11), p.2691

2022

Link zum Volltext

Verfügbarkeit prüfen

Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations

Cancers, 2023-05, Vol.15 (9), p.2592

2023

Link zum Volltext

Verfügbarkeit prüfen

Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC

Cancers, 2022-03, Vol.14 (7), p.1696

2022

Link zum Volltext

Verfügbarkeit prüfen

Response Assessment and Prediction of Progression-Free Survival by 68Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy

Biomolecules (Basel, Switzerland), 2021-07, Vol.11 (8), p.1099

2021

Link zum Volltext

Verfügbarkeit prüfen

Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery

World journal of surgical oncology, 2018-02, Vol.16 (1), p.35-35, Article 35

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(73)
Deutsch
(11)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Extracellular vesicles in urological malignancies: an update

177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)

Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model

Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model

New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide

Structure of the mammalian oligosaccharyl-transferase complex in the native ER protein translocon

Publisher Correction: Extracellular vesicles in urological malignancies: an update

Can local treatment prolong the sensitivity of metastatic prostate cancer to androgen deprivation or even prevent castration resistance?

The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors

Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function

BiP-mediated closing of the Sec61 channel limits Ca2+ leakage from the ER

Last Resort from Nursing Shortage? Comparative Cost Analysis of Open vs. Robot-Assisted Partial Nephrectomies with a Focus on the Costs of Nursing Care

Neuron-specific enolase has potential value as a biomarker for [18F]FDG/[68Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients

Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis

Primary Tumor Resection Decelerates Disease Progression in an Orthotopic Mouse Model of Metastatic Prostate Cancer

Histologically Confirmed Testicular Metastasis Revealed by [ 89 Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging

Patient-derived, three-dimensional spheroid cultures provide a versatile translational model for the study of organ-confined prostate cancer

Organ-Specific Uptake of Extracellular Vesicles Secreted by Urological Cancer Cells

Active surveillance inclusion criteria under scrutiny in magnetic resonance imaging-guided prostate biopsy: a multicenter cohort study

Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLT

Addition of Standard Enzalutamide Medication Shows Synergistic Effects on Response to [ 177 Lu]Lu-PSMA-617 Radioligand Therapy in mCRPC Patients with Imminent Treatment Failure-Preliminary Evidence of Pilot Experience

Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations

Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC

Response Assessment and Prediction of Progression-Free Survival by 68Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy

Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery

Suchergebnisse filtern